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Abstract Alcohol dehydrogenase (ADH) activity has been 
detected in all arteries and veins examined from humans and 
rat. In distinct human autopsy vessels, activity values range from 
0.9 ± 0 . 2 to 9.9 ± 7 . 7 mU/mg. Distribution of the activity in 
human aorta was: intima (23.5%), media (74%) and adventia 
(2.5%). In most of the samples the ß l ß l isozyme of class I A D H 
was the only form responsible for the ADH activity. Class IV 
ADH (oa-ADH) was present in three of the 28 individuals 
examined. The rat blood vessels showed class IV, but not class I, 
ADH localized in endothelium and media. The physiological role 
of vascular A D H is probably related to retinoid metabolism and 
elimination of lipid peroxidation aldehydes. A contribution to 
human ethanol metabolism is supported by the significant 
amount of low-iTm activity and the extension of the vascular 
system. 
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1. Introduction 
Ethanol exerts different effects on the cardiovascular sys-
tem. Depending upon the concentration of ethanol employed 
and the type of vessel investigated, ethanol can produce vaso-
dilatation or vasoconstriction [1]. It has also been suggested 
that both acute and chronic ethanol ingestion contribute to 
the etiology of hypertension, coronary heart disease, and 
stroke, and that acetaldehyde plays a role in the cardiovascu-
lar effects of ethanol [2-4]. In contrast, several studies have 
shown that moderate drinking protects against coronary dis-
ease (for reviews see [2,5]). One of the possible origins of both 
the negative and positive effects of ethanol on the cardiovas-
cular system is the metabolism of ethanol by the same system, 
with the concomitant in situ production of acetaldehyde and 
N A D H . The presence of a class I alcohol dehydrogenase 
(ADH) isozyme in human aorta has been reported [6] but 
the level of A D H activity and, therefore, the importance of 
ethanol metabolism in the blood vessels was not known. In 
the present work we recognize the A D H forms present in 
vascular tissues, report the A D H activity in different types 
of blood vessels, and estimate the contribution of the vascular 
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system to human ethanol metabolism. In addition we have 
investigated the presence of A D H in the blood vessels of the 
rat, the most frequently used species in toxicological studies of 
ethanol. 
2. Materials and methods 
2.1. Human tissues 
Different veins and arteries were obtained at autopsy, 12-24 h post-
mortem, from individuals (25-75 years old) without circulatory system 
disease. Blood vessel biopsies were also obtained at surgery of subjects 
with vascular diseases (varicose veins and atherosclerosis) or trauma. 
All samples were carefully cleaned from remaining blood by rinsing 
thoroughly in distilled water, and stored at —80°C. Prior to analysis 
the specimens were thawed, cut into small fractions and homogenized. 
Crude homogenates were centrifuged (24000Xg, 1 h) and superna-
tants were used for activity and electrophoretic analyses. 
2.2. Rat tissues 
Sprague-Dawley rats (250-350 g) were used. After being killed dis-
tinct blood vessel types from six animals were dissected, samples of 
each type were pooled and kept frozen at —80°C until analysis. Tis-
sues were processed under the same conditions as those for the human 
samples. 
2.3. Histochemical staining 
Sections 20 urn thick were cut in a cryostat (Leica) at —20°C, 
mounted on poly-L-lysine-coated slides and kept at —80°C until use. 
Prior to staining, sections were dried at room temperature for 30 min, 
then incubated for 1 h at 42°C in the dark in a staining solution 
containing 50 mM sodium phosphate, pH 7.6, 5 mM NAD, 2 mM 
4-methylpyrazole, 11 mM pyruvic acid, 3.4 mM nitroblue tetrazolium, 
and 500 mM ethanol as a substrate. After staining, the slides were 
washed with phosphate-buffered saline, fixed with 4% paraformalde-
hyde neutral solution for 10 min, dehydrated in ethanol/water, cleared 
in xylene, and moistened in DPX. 
2.4. RNA analysis 
Total RNA was isolated by the guanidine isothiocyanate method 
[7]. PolyA+-RNA was purified by using the PolyAtract System 1000 
(Promega). First-strand cDNA synthesis was performed with a Noil 
primer-adaptor (Promega) as a primer. A 1 ul aliquot from the cDNA 
reaction was subsequently used as a template in a PCR mixture to 
amplify a 449-bp fragment of class IV cDN A, as previously described 
[8]. PCR products were separated on a 1% agarose gel, transferred to 
a Nylon membrane (BioRad) and subjected to hybridization for 24 h 
with a dUTP-digoxigenin-labeled class IV-specific probe. Detection 
was performed by incubation at 37°C for 15 min with the chemilumi-
nescent substrate AMPPD, and exposure to an X-ray film for 15 s. 
2.5. Enzymology and protein analysis 
Alcohol dehydrogenase activity was determined by measurement in 
a Cary 219 spectrophotometer, the increase of absorbance at 340 nm, 
due to NADH formation. The enzymatic assay was performed at 
25°C in 0.1 M Gly/NaOH, pH 10.0, 2.4 mM NAD, and 33 mM or 
1 M ethanol for the human and rat tissues, respectively. Activities are 
expressed in mU (nmols NADH produced per min)/mg protein, and 
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Fig. 1. Starch gel electrophoresis of homogenates from human samples. A: Activity staining with crotyl alcohol. Lane 1: aorta; lane 2: liver; 
lane 3: esophagus. Samples are from different individuals. B: Activity staining with ethanol. Lanes 4-6: superior vena cava, portal vein and 
aorta, respectively, from the same individual. All samples were obtained at autopsy. 
indicated as the mean±SD. Protein was determined using the Bio-
Rad protein assay. Starch gel electrophoresis was performed as pre-
viously reported [9], using 0.1 M crotyl alcohol or 0.2 M ethanol for 
the activity staining. 
The study was approved by the Ethical Committees of the Univer-
sität Autónoma de Barcelona and Hospital de Tarragona Joan XXIII. 
Informed written consent was obtained from each patient before sur-
gery. 
3. Results 
3.1. Alcohol dehydrogenase in human blood vessels 
Blood vessel samples were obtained from eight individuals 
at autopsy and from surgical biopsy of 20 individuals. The 
homogenates of biopsy samples exhibited little ethanol dehy-
drogenase activity and, in general, faint bands of activity were 
observed on starch gel electrophoresis. In contrast, the sam-
ples obtained at autopsy were much more active, and ADH 
bands clearly distinguished by electrophoresis (Fig. 1). Appar-
ently the amount of active enzyme was much higher in post-
mortem but healthy tissue than in biopsies of blood vessels 
with pathology. The class III ADH bands were observed in all 
samples stained with crotyl alcohol, including those from bi-
opsies. In all samples with measurable ethanol dehydrogenase 
activity, the ßlßl-ADH isozyme could be always detected by 
electrophoresis. All blood vessels analyzed (Table 1 and Fig. 
1) exhibited the isozyme. In samples from three individuals 
(two from autopsy and one from biopsy) oo-ADH, the class 
IV ADH, was also clearly detected (Fig. 1). 
All specimens obtained at autopsy exhibited measurable 
ADH activity (Table 1). The wide range of the activity values 
found for each vessel type results from the interindividual 
variability. Some subjects exhibited high activity levels for 
all vessels analyzed, while others showed low activities for 
all vascular tissues. At present the source of this variability 
is not clear. It is not related to the age of the patient, neither 
to the post-mortem time. 
Activity of the different layers dissected from a human aor-
ta was measured in the most active specimen, exhibiting 19 
mU/mg protein and 94 mU/g fresh tissue. Activity was present 
in all layers although the contribution of the media was the 
highest, about 74%; the intima showed 23.5% of the activity, 
while the adventia only 2.5%. 
3.2. Alcohol dehydrogenase in rat blood vessels 
The typical alcohol dehydrogenase of the rat vessels is class 
IV, which is the ADH form characteristic of the stomach (Fig. 
2). Class I was not detected while class III ADH was barely 
observed in the rat vascular tissues. The activity was similar 
for each vessel studied (Table 1). A histochemical staining of a 
rat artery, under conditions for detection of class IV activity 
(in the presence of 2 mM 4-methylpyrazole to inhibit any class 
I activity), showed the highest activity in the media, lower 
activity in the intima and no activity in the adventia (Fig. 
3). The endothelial cells appeared clearly stained. Class IV 
cDNA was also detected in rat vessels by RT-PCR and sub-
sequent hybridization with a chemiluminescent class IV-spe-
cific probe (Fig. 4), demonstrating the presence of class IV 
mRNA. 
Table 1 
Alcohol dehydrogenase activity (mU/mg) in human and rat blood 
vessels 
Vessel 
Aorta 
Carotid 
Portal vein 
Inferior vena 
Superior vena 
cava 
cava 
Human («) 
9.9 ±7.7 (4) 
n.d. 
3.4 ±3.0 (5) 
0.9 ±0.2 (4) 
8.3 ±7.3 (4) 
Rat 
n.d. 
6.1 ±0.7 
6.5 ±0.6 
3.8 ±0.6 
5.3 ±1.0 
Human samples were obtained at autopsy. Rat samples from six ani-
mals were pooled, homogenized and analyzed in triplicate. 
n.d., not determined. 
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Fig. 2. Starch gel eleetrophoresis of rat tissue homogenates. Lane l: stomach; lanes 2-6: blood vessels: portal vein (2), superior vena cava (3), 
jugular vein (4), carotid artery (5), inferior vena cava (6); lane 7, liver. Gel was stained for activity with crotyl alcohol. 
4. Discussion 
4.1. Characteristics of alcohol dehydrogenase in blood vessels 
Human blood vessels exhibit significant alcohol dehydro-
genase activity. The ßlßl class I isozyme is responsible for 
most of this activity and is present in all vessels studied. Ac-
tivity is detected in all layers of the aorta, with a higher con-
tribution of the media. Contribution of the intima is signifi-
cant, while the adventia shows a small activity which may 
result from contamination of media cells. This distribution 
is consistent with the histochemical analysis of ADH in rat 
artery. All human vessels also contain the class III ADH 
form, i.e. the glutathione-dependent formaldehyde dehydro-
genase, whose contribution to ethanol metabolism is negli-
gible. In some individuals the class IV ADH is also detected. 
We do not know, with the present data, whether the presence 
of class IV ADH in a few individuals (3 out of 28) results 
from genetic polymorphism or from a lability of the enzyme, 
making it undetectable in most of our human samples. 
The rat blood vessels show alcohol dehydrogenase charac-
teristics different from those of the human vascular enzyme. 
We have demonstrated the presence of class IV, at both pro-
tein and mRNA levels, in the rat circulatory system. Class I 
was not detected. Histochemical analyses reveal that class IV 
is present in the arterial endothelium and mostly in the media, 
a layer formed by smooth muscle and connective tissue. This 
demonstrates that class IV, which was initially thought to be 
essentially an ADH of the epithelia [10,11], is also present in 
non-epithelial tissues. 
The physiological function of ADH in blood vessels is 
probably similar in both the human and rat species. Both class 
I and class IV are highly active in the transformation of al-
cohols and aldehydes of importance for the maintenance of 
the epithelia. Both enzymes can oxidize retinol to retinal, an 
important reaction for the production of retinoic acid, an 
essential modulator of epithelial development [11-13]. Recent 
evidence suggests that retinoids might also be involved in the 
differentiation and ageing of vascular smooth muscle cells 
[14]. Moreover, classes I and IV may play a relevant role in 
the elimination of aldehydes resulting from lipid peroxidation 
[12,15]. Class III ADH is also present in blood vessels, and is 
the main enzyme responsible for formaldehyde elimination, 
also a major product of lipid peroxidation. It is therefore 
reasonable that the set of ADH classes in blood vessels con-
stitutes a defence mechanism against cytotoxic aldehydes gen-
erated by lipid peroxidation in a highly oxygenated tissue. 
Glutathione-S-transferase, another enzyme involved in the 
elimination of these cytotoxic aldehydes, is also present in 
blood vessels [16]. Both enzymatic systems can, therefore, 
play a role in the protection against atherosclerosis since lipid 
peroxidation is believed to be a factor that stimulates the 
formation of the atherosclerotic plaque [17] and adducts of 
Fig. 3. Histochemical staining for ADH activity of rat arterial tissue 
sections. Original magnification: X 100. From lumen to the outer 
part of the vessel: intima, media, and adventia layers. A: 500 mM 
ethanol and 2 mM 4-methylpyrazole. B: No substrate was added. 
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Fig. 4. Detection of mRNA of ADH class IV from rat blood vessels by RT-PCR. Lane 1: Control sample without added DNA template; land 
2: PCR products from blood vessels; lane 3: pBR328 DNA digested with Bgñ and Hinß (molecular weight marker VI, Boehringer Mann-
heim); lane 4: PCR products from stomach. A: Ethidium-bromide staining after 1% agarose gel electrophoresis. B: Chemiluminescent bands 
after hybridization with a class IV-speciflc probe. The 449-bp band corresponds to a fragment of class IV cDNA. 
4-hydroxynonenal and lipoprotein have been localized in hu-
man atheroma [18]. 
4.2. Role of blood vessel alcohol dehydrogenase in ethanol 
metabolism 
The isozymes of the ADH2 gene are characteristically ex-
pressed in human vascular tissue. The ßlßl form shows a low 
Km for ethanol ( 7 ^ = 0.05 mM, kcaX = 9 min
- 1) [19] which 
makes it suitable for metabolizing the blood ethanol at the 
low concentration found after social drinking. Individuals ex-
pressing the ADH2*2 alíele will exhibit the highly active ß2ß2 
form (&Cat = 400 min
- 1), and therefore a much higher ADH 
activity in blood vessels. A contribution of class IV ADH 
could be also possible, at least in some individuals, in spite 
of the higher Km (37 mM), because of an extremely high kcaij 
(1510 min - 1) [8]. The importance of vascular ADH in ethanol 
metabolism may differ between individuals. Thus, values rang-
ing from 2.9 to 19 mU/mg have been found in human aorta 
samples from different subjects. 
Human blood vessels also contain a significant amount of 
ADH of the low-Ä^, type. Analysis by starch gel electropho-
resis demonstrates that both cytosolic (class 1) and mitochon-
drial (class 2) forms are present in all vessels studied (results 
not shown), while measurements using 66 ¡JM propanol as 
substrate, at pH 8.5, show an activity of about 1 mU/mg 
protein. This activity is lower than the ADH activity for 
most of the blood vessels, suggesting a possible local accumu-
lation of acetaldehyde in the vascular tissue due to alcohol 
oxidation by endogenous ADH. 
Rat class IV oxidizes ethanol poorly. Its Km at physiolog-
ical pH is extremely high (3 M), which makes the enzyme 
practically inactive at the pharmacological concentrations of 
ethanol [10]. Thus, with 33 mM ethanol, at pH 7.5 and 37°C, 
the activity is about 100-fold lower than the values reported in 
Table 1. The situation is quite different for the human species. 
Under physiological conditions the activity is similar to that 
reported in Table 1, with values close to those found in gastric 
mucosa [9,20]. Since the low-Km ßß form is responsible for 
most of the activity, the enzyme will be readily saturated at 
usual blood ethanol concentrations, and therefore with max-
imal velocity. All blood vessels examined contained the iso-
zyme, which has been localized in the endothelium and lamina 
media (present work and [6]). The presence of ADH in endo-
thelium has been also demonstrated in rat arteries (Fig. 3) and 
veins (not shown) by histochemical analysis, suggesting a wide 
distribution of the enzyme in the whole vascular system. The 
vascular endothelium corresponds to an enormous surface 
when all vessels of the human body are considered (estimates 
of 500-700 m2, [21]). It is therefore likely that blood vessels 
contribute significantly to extrahepatic ethanol metabolism. 
ADH of blood vessels may also have a role in the first-pass 
metabolism of ethanol. The origin of this first pass is contro-
versial. Physiological experiments support a role of stomach 
ADH in the first pass [22], but the amount of enzyme is low in 
gastric tissue [9,20]. The enzyme of the blood vessels can ox-
idize ethanol during the absorption from the stomach and 
intestine, and during the first passage through the veins to 
the lungs, before it reaches the general circulation. The con-
tribution of vascular ADH to the overall and first-pass me-
tabolism of ethanol may be significant in humans but of less 
importance in the rat, where vascular ADH has low activity 
with ethanol. 
The presence of some level of ethanol metabolism in blood 
vessels has been interpreted as a positive mechanism of pre-
venting cardiovascular diseases through maintenance of a re-
duced environment in the vessel and minimization of lipopro-
tein oxidation [6]. However, several reports support the 
possibility that some of the detrimental effects of ethanol 
are mediated via increased oxidative stress which would be, 
at least in part, induced by ethanol metabolism, that in addi-
tion may lead to lipid accumulation [2,23,24]. Moreover, etha-
nol metabolism by vascular ADH could interfere with the 
proposed function of this enzyme in the elimination of lipid 
peroxidation products, therefore contributing to vascular 
damage. 
Some of the direct effects of ethanol on blood vessels [1] can 
be a consequence of its metabolism, particularly through the 
action of the in situ generated acetaldehyde. Concentration of 
blood acetaldehyde is low even at intoxicating ethanol doses; 
however, the acetaldehyde concentration in the blood vessel 
tissues could be higher because of local ethanol metabolism, 
suggesting a stronger cardiovascular effect of this toxic com-
pound than previously thought [1,25], and a contribution of 
blood vessel acetaldehyde to the flushing response of Orien-
tals. Finally, it has been suggested that some acetaldehyde 
effects, such as the stimulation of vascular prostacyclin re-
lease, may take part in the protective effect of moderate con-
sumption against some cardiovascular complications [26]. In 
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conclusion, the metabolism of ethanol in blood vessels by 
alcohol dehydrogenase represents a new mechanism to explain 
the effects of ethanol on the cardiovascular system. 
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